MCOLN2, TRPV4, and ITPR2 were significantly highly expressed in glioma tissues, and the three most significantly down-regulated genes (PRKCG, CAMK2A, and HTR2A) had lower expression in tumor tissues (Fig. 2A). This evidence concerns the gene PRKCG and central nervous system cancer.